A citation-based method for searching scientific literature

Anna F Farago, Long P Le, Zongli Zheng, Alona Muzikansky, Alexander Drilon, Manish Patel, Todd M Bauer, Stephen V Liu, Sai-Hong I Ou, David Jackman, Daniel B Costa, Pratik S Multani, Gary G Li, Zachary Hornby, Edna Chow-Maneval, David Luo, Jonathan E Lim, Anthony J Iafrate, Alice T Shaw. J Thorac Oncol 2015
Times Cited: 144



Jaclyn F Hechtman, Ryma Benayed, David M Hyman, Alexander Drilon, Ahmet Zehir, Denise Frosina, Maria E Arcila, Snjezana Dogan, David S Klimstra, Marc Ladanyi, Achim A Jungbluth. Am J Surg Pathol 2017
Times Cited: 190




List of shared articles



Times cited

Evaluation of NTRK immunohistochemistry as a screening method for NTRK gene fusion detection in non-small cell lung cancer.
Hedvig Elfving, Erika Broström, Lotte N J Moens, Jonas Almlöf, Dijana Cerjan, Gilbert Lauter, Helena Nord, Johanna S M Mattsson, Gustav J Ullenhag, Carina Strell,[...]. Lung Cancer 2021
3

An improved assay for detection of theranostic gene translocations and MET exon 14 skipping in thoracic oncology.
Nicolas Piton, Marie-Delphine Lanic, Florent Marguet, Aude Lamy, France Blanchard, Florian Guisier, Mathieu Viennot, Mathieu Salaün, Luc Thiberville, Fabrice Jardin,[...]. Lab Invest 2021
0

Identification of NTRK gene fusions in lung adenocarcinomas in the Chinese population.
Ruiying Zhao, Feng Yao, Chan Xiang, Jikai Zhao, Zhanxian Shang, Lianying Guo, Wenjie Ding, Shengji Ma, Anbo Yu, Jinchen Shao,[...]. J Pathol Clin Res 2021
0

Applicability of pan-TRK immunohistochemistry for identification of NTRK fusions in lung carcinoma.
Simon Strohmeier, Iva Brcic, Helmut Popper, Bernadette Liegl-Atzwanger, Jörg Lindenmann, Luka Brcic. Sci Rep 2021
1

MLH1/PMS2 Expression Could Tell Classical NTRK Fusion in Fluorescence In Situ Hybridization Positive Colorectal Carcinomas.
Yao Fu, Zheng Li, Fuping Gao, Jun Yang, Hongyan Wu, Biao Zhang, Xiaohong Pu, Xiangshan Fan. Front Oncol 2021
0

Methods for Identifying Patients with Tropomyosin Receptor Kinase (TRK) Fusion Cancer.
Derek Wong, Stephen Yip, Poul H Sorensen. Pathol Oncol Res 2020
16

NTRK gene rearrangements are highly enriched in MLH1/PMS2 deficient, BRAF wild-type colorectal carcinomas-a study of 4569 cases.
Angela Chou, Tamara Fraser, Mahsa Ahadi, Talia Fuchs, Loretta Sioson, Adele Clarkson, Amy Sheen, Nisha Singh, Christopher L Corless, Anthony J Gill. Mod Pathol 2020
23

Tropomyosin receptor kinase inhibitors in the management of sarcomas.
Christopher P Wilding, Herbert H Loong, Paul H Huang, Robin L Jones. Curr Opin Oncol 2020
2

NTRK Fusions, from the Diagnostic Algorithm to Innovative Treatment in the Era of Precision Medicine.
Federica Zito Marino, Francesca Pagliuca, Andrea Ronchi, Immacolata Cozzolino, Marco Montella, Massimiliano Berretta, Maria Elena Errico, Vittoria Donofrio, Roberto Bianco, Renato Franco. Int J Mol Sci 2020
14

Challenges in the Diagnosis of NTRK Fusion-Positive Cancers.
Oliver Gautschi, Lukas Bubendorf, Serge Leyvraz, Roopika Menon, Joachim Diebold. J Thorac Oncol 2020
2

Molecular characterization of cancers with NTRK gene fusions.
Zoran Gatalica, Joanne Xiu, Jeffrey Swensen, Semir Vranic. Mod Pathol 2019
177

TRK Fusion Cancers in Children: A Clinical Review and Recommendations for Screening.
Catherine M Albert, Jessica L Davis, Noah Federman, Michela Casanova, Theodore W Laetsch. J Clin Oncol 2019
37

Testing algorithm for identification of patients with TRK fusion cancer.
Frédérique Penault-Llorca, Erin R Rudzinski, Antonia R Sepulveda. J Clin Pathol 2019
68


Antitumor activity of larotrectinib in tumors harboring NTRK gene fusions: a short review on the current evidence.
Biagio Ricciuti, Carlo Genova, Lucio Crinò, Massimo Libra, Giulia Costanza Leonardi. Onco Targets Ther 2019
22


ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research.
C Marchiò, M Scaltriti, M Ladanyi, A J Iafrate, F Bibeau, M Dietel, J F Hechtman, T Troiani, F López-Rios, J-Y Douillard,[...]. Ann Oncol 2019
102


Tropomyosin receptor kinase (TRK) biology and the role of NTRK gene fusions in cancer.
A Amatu, A Sartore-Bianchi, K Bencardino, E G Pizzutilo, F Tosi, S Siena. Ann Oncol 2019
32

Identifying patients with NTRK fusion cancer.
J P Solomon, R Benayed, J F Hechtman, M Ladanyi. Ann Oncol 2019
61


Emerging Targeted Therapy for Tumors with NTRK Fusion Proteins.
Ed S Kheder, David S Hong. Clin Cancer Res 2018
56


Brief Report: Potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade glioma.
David S Ziegler, Marie Wong, Chelsea Mayoh, Amit Kumar, Maria Tsoli, Emily Mould, Vanessa Tyrrell, Dong-Anh Khuong-Quang, Mark Pinese, Velimir Gayevskiy,[...]. Br J Cancer 2018
51

TRK Inhibition: A New Tumor-Agnostic Treatment Strategy.
Shivaani Kummar, Ulrik N Lassen. Target Oncol 2018
43